S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

MYMD MyMD Pharmaceuticals Inc

1.82

0.00 (0.00%)

Pre Market

Last Updated: 11:00:00

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

MyMD Pharmaceuticals (NASDAQ:MYMD)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more MyMD Pharmaceuticals Charts.

MyMD Pharmaceuticals (NASDAQ:MYMD)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more MyMD Pharmaceuticals Charts.

MyMD Pharmaceuticals Inc News

TNF Pharmaceuticals (Formerly MyMD Pharmaceuticals) Begins Trading Under New Nasdaq Stock Symbol “TNFA” Effective Before Market Open Today
Wednesday 24 July 2024 (7 months ago) • Business Wire

MyMD Pharmaceuticals Announces Corporate Rebranding to New Name TNF Pharmaceuticals, Inc.
Monday 22 July 2024 (7 months ago) • Business Wire

Form 8-K - Current report
Monday 17 June 2024 (8 months ago) • Edgar (US Regulatory)

MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical Officer
Monday 17 June 2024 (8 months ago) • Business Wire

Form D - Notice of Exempt Offering of Securities
Friday 31 May 2024 (9 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 24 May 2024 (9 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 21 May 2024 (9 months ago) • Edgar (US Regulatory)

MyMD Pharmaceuticals Secures Strategic Investments
Tuesday 21 May 2024 (9 months ago) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 16 May 2024 (9 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 March 2024 (12 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 6 March 2024 (12 months ago) • Edgar (US Regulatory)

MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
Wednesday 6 March 2024 (12 months ago) • Business Wire

More MyMD Pharmaceuticals Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions